Skip to main content
. Author manuscript; available in PMC: 2014 Oct 9.
Published in final edited form as: Br J Haematol. 2012 Jun 15;158(5):581–588. doi: 10.1111/j.1365-2141.2012.09186.x

Table 2.

Patient characteristics (N=61)

Number of patients 61
Age (years)
    Median 58
    Range 25-82
Sex
    Male 40 (66%)
    Female 21 (34%)
Eastern Cooperative Oncology Group Performance Status
    0 14 (23%)
    1 36 (59%)
    2 11 (18%)

Number of previous chemotherapy regimens
    2 49 (80%)
    3 9 (15%)
    4 2 (3%)

Concomitant use of medication
    Antineoplastic agents (hydroxycarbamide) 9 (15%)
    Immunostimulants (granulocyte colony-stimulating factor) 14 (23%)